The pharmaceutical landscape is witnessing a change with the arrival of GLP-1 transdermal systems . These innovative formulations offer a possible alternative to providing glucagon-like peptide-1 https://kianaqaif063114.thelateblog.com/41285181/glp-1-patches-a-novel-way-to-treat-blood-sugar